OTC · Real Estate

SELECTIS HEALTH, INC. (GBCS)

As-reported financials and recent SEC filings for SELECTIS HEALTH, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$41.4M

Net income

$-1.0M

Net margin

-2.5%

Diluted EPS

$-0.34

ROE

16.4%

P/E (TTM)

—

Market cap

—

Debt / equity

-2.2×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$41.4M	$39.5M	$36.8M	$40.6M	$29.3M
Gross profit	—	—	—	—	—
Operating income	$-1.6M	$-2.7M	$-9.0M	$-286,572	$-728,992
Net income	$-1.0M	$-2.4M	$-4.0M	$-2.4M	$-2.3M
Diluted EPS	$-0.34	$-0.80	$-1.31	$-0.79	$-0.82

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

8-K2026-06-24

SC TO-C2026-06-23

32026-05-26

10-Q2026-05-22

8-K2026-05-20

NT 10-Q2026-05-14

8-K2026-05-07

SC TO-T/A2026-05-01

Largest Real Estate peers

JONES LANG LASALLE INC

$26.12B revenue

AMT

AMERICAN TOWER CORP /MA/

$10.64B revenue

CWK

Cushman & Wakefield Ltd.

All Real Estate companies →

Go deeper on GBCS

Search SELECTIS HEALTH, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.